This video addresses common misconceptions about marijuana including the adverse side effects as well as whether the use of marijuana can help alleviate the symptoms of some diseases. It also looks at the different strains of marijuana, the active chemicals found within them and the differences between medicinal and recreational marijuana.

This video was made by McMaster Demystifying Medicine students Kavena Sivakumar, Alice Nassar, Halla Rahman, Waleed Dhillon & Elise MacLean

Copyright McMaster University 2017

Please let us know how you liked this video and suggest additional topics for us to demystify below.

References:

Hillig, K. W., & Mahlberg, P. G. (2004). A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). American Journal of Botany, 91(6), 966-975.

Prevalence and correlates of marijuana use in Canada, 2012. (2015, November 27). Retrieved February 12, 2017, from HYPERLINK “http://www.statcan.gc.ca/pub/82-003-x/2015004/article/14158-eng.htm” http://www.statcan.gc.ca/pub/82-003-x/2015004/article/14158-eng.htm

=Ilan, A. B., Gevins, A., Coleman, M., ElSohly, M. A., & De Wit, H. (2005). Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behavioural pharmacology, 16(5-6), 487-496.

Burgdorf, J. R., Kilmer, B., & Pacula, R. L. (2011). Heterogeneity in the composition of marijuana seized in California. Drug and alcohol dependence, 117(1), 59-61.

Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. S. (2012). Interaction between cannabidiol (CBD) and∆ 9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids. Psychopharmacology, 219(1), 247-249.

Anderson, L. C. (1980). Leaf variation among Cannabis species from a controlled garden. Botanical Museum Leaflets, Harvard University, 28(1), 61-69.

Hillig, K. W., & Mahlberg, P. G. (2004). A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). American Journal of Botany, 91(6), 966-975.

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimaraes, F. S. (2006). Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Brazilian Journal of Medical and Biological Research, 39(4), 421-429.

Kogan, N. M., & Mechoulam, R. (2007). Cannabinoids in health and disease. Dialogues in clinical neuroscience, 9(4), 413.

Jay, C., Shade, S., Vizoso, H., Reda, H., Petersen, K., Rowbotham, M., & Abrams, D. (2004). The effect of smoked marijuana on chronic neuropathic and experimentally induced pain in HIV neuropathy: Results of an open-label pilot study. University of California, San Francisco: February, 8-11.

Machado Rocha, F. C., Stefano, S. C., De Cassia Haiek, R., Rosa Oliveira, L. M. Q., & Da Silveira, D. X. (2008). Therapeutic use of Cannabis sativa on chemotherapy‐induced nausea and vomiting among cancer patients: systematic review and meta‐analysis. European journal of cancer care, 17(5), 431-443.

Campbell, F. A., Tramèr, M. R., Carroll, D., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001). Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. Bmj, 323(7303), 13.

Koppel, B. S., Brust, J. C., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., & Gloss, D. (2014). Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 82(17), 1556-1563.

Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219-2227.

Zalesky, A., Solowij, N., Yücel, M., Lubman, D. I., Takagi, M., Harding, I. H., … & Seal, M. (2012). Effect of long-term cannabis use on axonal fibre connectivity. Brain, 135(7), 2245-2255.

Tashkin, D. P. (2013). Effects of marijuana smoking on the lung. Annals of the American Thoracic Society, 10(3), 239-247.